Conceptio › Archive › ClinicalTrials.gov
ClinicalTrials.govpublic full text

Olaparib Treatment in BRCA Mutated Ovarian Cancer Patients After Complete or Partial Response to Platinum Chemotherapy

AstraZeneca · 2013
ClinicalTrials.gov · Datasets · License: Public Domain · 2013
Open Source ↗
chemotherapyovariancancer
platinum sensitive, brca mutated, relapsed ovarian cancer, following complete or partial response to platinum based chemotherapy, brca, ovarian cancer, chemotherapy, parp inhibitor, interventional, phase3
This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Related documents

Record · ID 918549
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.